Dr Bird Neuro Psychiatry Ltd Filleted accounts for Companies House (small and micro)

DR BIRD NEURO PSYCHIATRY LTD - Company Information

false false false false false false false false false true false false false false false false false 2017-04-01 Sage Accounts Production Advanced 2018 - FRS 10,000 10,000 6,500 6,500 6,500 xbrli:pure xbrli:shares iso4217:GBP 07174918 2017-04-01 2018-03-31 07174918 2018-03-31 07174918 2017-03-31 07174918 2016-04-01 2017-03-31 07174918 2017-03-31 07174918 core:NetGoodwill 2017-04-01 2018-03-31 07174918 core:PlantMachinery 2017-04-01 2018-03-31 07174918 core:FurnitureFittings 2017-04-01 2018-03-31 07174918 bus:Director1 2017-04-01 2018-03-31 07174918 core:NetGoodwill 2018-03-31 07174918 core:PlantMachinery 2017-03-31 07174918 core:FurnitureFittings 2017-03-31 07174918 core:PlantMachinery 2018-03-31 07174918 core:FurnitureFittings 2018-03-31 07174918 core:WithinOneYear 2018-03-31 07174918 core:WithinOneYear 2017-03-31 07174918 core:ShareCapital 2018-03-31 07174918 core:ShareCapital 2017-03-31 07174918 core:RetainedEarningsAccumulatedLosses 2018-03-31 07174918 core:RetainedEarningsAccumulatedLosses 2017-03-31 07174918 core:CostValuation core:Non-currentFinancialInstruments 2018-03-31 07174918 core:Non-currentFinancialInstruments 2018-03-31 07174918 core:Non-currentFinancialInstruments 2017-03-31 07174918 core:AcceleratedTaxDepreciationDeferredTax 2018-03-31 07174918 core:AcceleratedTaxDepreciationDeferredTax 2017-03-31 07174918 core:PlantMachinery 2017-03-31 07174918 core:FurnitureFittings 2017-03-31 07174918 bus:SmallEntities 2017-04-01 2018-03-31 07174918 bus:AuditExemptWithAccountantsReport 2017-04-01 2018-03-31 07174918 bus:FullAccounts 2017-04-01 2018-03-31 07174918 bus:SmallCompaniesRegimeForAccounts 2017-04-01 2018-03-31 07174918 bus:PrivateLimitedCompanyLtd 2017-04-01 2018-03-31

COMPANY REGISTRATION NUMBER: 07174918

Dr Bird Neuro Psychiatry Ltd

Filleted Unaudited Financial Statements

31 March 2018

Dr Bird Neuro Psychiatry Ltd

Statement of Financial Position

31 March 2018

	2018		2017
Note	£	£	£

Fixed assets

Tangible assets	6	9,361	10,696
Investments	7	6,500	6,500
		ÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄ
		15,861	17,196

Current assets

Debtors	8	129,628	114,773
Cash at bank and in hand		54,753	55,014
		ÄÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄÄ
		184,381	169,787

Creditors: amounts falling due within one year	9	95,131		66,586
		ÄÄÄÄÄÄÄÄÄ		ÄÄÄÄÄÄÄÄÄ
Net current assets			89,250	103,201
			ÄÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄÄ
Total assets less current liabilities			105,111	120,397

Provisions

Taxation including deferred tax	1,810	2,032
	ÄÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄÄ
Net assets	103,301	118,365
	ÍÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍÍ

Capital and reserves

Called up share capital	2	2
Profit and loss account	103,299	118,363
	ÄÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄÄ
Shareholders funds	103,301	118,365
	ÍÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍÍ

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.

For the year ending 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Dr Bird Neuro Psychiatry Ltd

Statement of Financial Position (continued)

31 March 2018

These financial statements were approved by the board of directors and authorised for issue on 19 December 2018 , and are signed on behalf of the board by:

Dr J M Bird
Director

Company registration number: 07174918

Dr Bird Neuro Psychiatry Ltd

Notes to the Financial Statements

Year ended 31 March 2018

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Old Stables, Bristol Road, Hambrook, BS16 1RB. The principal activity of the company during the year was Medical Consultancy .

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits with banks and other short term highly liquid investments.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	20% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Plant & equipment	-	15% reducing balance
Fixtures & fittings	-	15% reducing balance

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 1 (2017: 2 ).

5. Intangible assets

	Goodwill
	£
Cost
At 1 April 2017 and 31 March 2018	10,000
	ÍÍÍÍÍÍÍÍ
Amortisation
At 1 April 2017 and 31 March 2018	10,000
	ÍÍÍÍÍÍÍÍ
Carrying amount
At 31 March 2018	–
	ÍÍÍÍÍÍÍÍ
At 31 March 2017	–
	ÍÍÍÍÍÍÍÍ

6. Tangible assets

	Plant and machinery	Fixtures and fittings	Total
	£	£	£
Cost
At 1 April 2017	7,704	12,127	19,831
Additions	317	–	317
	ÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄ
At 31 March 2018	8,021	12,127	20,148
	ÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ
Depreciation
At 1 April 2017	3,758	5,377	9,135
Charge for the year	639	1,013	1,652
	ÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄ
At 31 March 2018	4,397	6,390	10,787
	ÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ
Carrying amount
At 31 March 2018	3,624	5,737	9,361
	ÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ
At 31 March 2017	3,946	6,750	10,696
	ÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ

7. Investments

	Other investments other than loans
	£
Cost
At 1 April 2017 and 31 March 2018	6,500
	ÍÍÍÍÍÍÍ
Impairment
At 1 April 2017 and 31 March 2018	–
	ÍÍÍÍÍÍÍ

Carrying amount
At 31 March 2018	6,500
	ÍÍÍÍÍÍÍ
At 31 March 2017	6,500
	ÍÍÍÍÍÍÍ

The investment is a painting valued at cost.

8. Debtors

	2018	2017
	£	£
Trade debtors	127,756	113,331
Other debtors	1,872	1,442
	ÄÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄÄ
	129,628	114,773
	ÍÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍÍ

9. Creditors: amounts falling due within one year

	2018	2017
	£	£
Social security and other taxes	68,746	63,411
Other creditors	26,385	3,175
	ÄÄÄÄÄÄÄÄ	ÄÄÄÄÄÄÄÄ
	95,131	66,586
	ÍÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍÍ

10. Deferred tax

The deferred tax included in the statement of financial position is as follows:

	2018	2017
	£	£
Included in provisions	1,810	2,032
	ÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍ

The deferred tax account consists of the tax effect of timing differences in respect of:

	2018	2017
	£	£
Accelerated capital allowances	1,810	2,032
	ÍÍÍÍÍÍÍ	ÍÍÍÍÍÍÍ

11. Director's advances, credits and guarantees

At 31 March 2018, the company owed £22,482 to the director. As at 31 March 2017 the director owed £1,019 to the company. There have been no advances, credits or guarantees such as are required to be disclosed under FRS102.

12. Related party transactions

During the year rent of £3,600 (2017: £3,600) was paid to the directors. There are no other related party transactions such as are required to be disclosed under FRS102 Section 1AC.35.